Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.
Miller JW, Schmidt-Erfurth U, Sickenberg M, Pournaras CJ, Laqua H, Barbazetto I, Zografos L, Piguet B, Donati G, Lane AM, Birngruber R, van den Berg H, Strong A, Manjuris U, Gray T, Fsadni M, Bressler NM, Gragoudas ES. Miller JW, et al. Among authors: strong a. Arch Ophthalmol. 1999 Sep;117(9):1161-73. doi: 10.1001/archopht.117.9.1161. Arch Ophthalmol. 1999. PMID: 10496388 Clinical Trial.
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.
Blumenkranz MS, Bressler NM, Bressler SB, Donati G, Fish GE, Haynes LA, Lewis H, Miller JW, Monés JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld PJ, Schachat AP, Schmidt-Erfurth U, Sickenburg M, Singerman LJ, Slakter JS, Strong A, Vannier S; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Blumenkranz MS, et al. Among authors: strong a. Arch Ophthalmol. 2002 Oct;120(10):1307-14. doi: 10.1001/archopht.120.10.1307. Arch Ophthalmol. 2002. PMID: 12365909 Clinical Trial.
Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: four-year results of an open-label extension of 2 randomized clinical trials: TAP Report No. 7.
Bressler NM, Bressler SB, Haynes LA, Hao Y, Kaiser PK, Miller JW, Naor J, Potter MJ, Pournaras CJ, Reaves A, Rosenfeld PJ, Schmidt-Erfurth U, Slakter JS, Strong A, Vannier S. Bressler NM, et al. Among authors: strong a. Arch Ophthalmol. 2005 Sep;123(9):1283-5. doi: 10.1001/archopht.123.9.1283. Arch Ophthalmol. 2005. PMID: 16157822 Clinical Trial. No abstract available.
Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographic examples.
Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, Zografos L, Birngruber R, van den Bergh H, Strong A, Manjuris U, Fsadni M, Lane AM, Piguet B, Bressler NM. Schmidt-Erfurth U, et al. Among authors: strong a. Graefes Arch Clin Exp Ophthalmol. 1998 May;236(5):365-74. doi: 10.1007/s004170050092. Graefes Arch Clin Exp Ophthalmol. 1998. PMID: 9602321 Clinical Trial.
Improvement after verteporfin therapy.
Anand R, Bressler NM, Bressler SB, Gray TE, Harvey P, Haynes L, Koester JM, Manos KS, Miller JW, Murphy S, Reaves A, Sickenberg M, Singerman LJ, Strong A, Stur M; "Improvement After Verteporfin Therapy" Writting Committee for TAP Study Group. Anand R, et al. Among authors: strong a. Arch Ophthalmol. 2003 Mar;121(3):415-6. doi: 10.1001/archopht.121.3.415. Arch Ophthalmol. 2003. PMID: 12617718 No abstract available.
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: meta-analysis of 2-year safety results in three randomized clinical trials: Treatment Of Age-Related Macular Degeneration With Photodynamic Therapy and Verteporfin In Photodynamic Therapy Study Report no. 4.
Azab M, Benchaboune M, Blinder KJ, Bressler NM, Bressler SB, Gragoudas ES, Fish GE, Hao Y, Haynes L, Lim JI, Menchini U, Miller JW, Mones J, Potter MJ, Reaves A, Rosenfeld PJ, Strong A, Su XY, Slakter JS, Schmidt-Erfurth U, Sorenson JA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group; Verteporfin in Photodynamic Therapy (VIP) Study Group. Azab M, et al. Among authors: strong a. Retina. 2004 Feb;24(1):1-12. doi: 10.1097/00006982-200402000-00001. Retina. 2004. PMID: 15076937
Clinical pharmacokinetics of verteporfin.
Houle JM, Strong A. Houle JM, et al. Among authors: strong a. J Clin Pharmacol. 2002 May;42(5):547-57. doi: 10.1177/00912700222011607. J Clin Pharmacol. 2002. PMID: 12017349 Clinical Trial.
Inferred cosmic-ray spectrum from Fermi large area telescope γ-ray observations of Earth's limb.
Ackermann M, Ajello M, Albert A, Allafort A, Baldini L, Barbiellini G, Bastieri D, Bechtol K, Bellazzini R, Blandford RD, Bloom ED, Bonamente E, Bottacini E, Bouvier A, Brandt TJ, Brigida M, Bruel P, Buehler R, Buson S, Caliandro GA, Cameron RA, Caraveo PA, Cecchi C, Charles E, Chaves RC, Chekhtman A, Chiang J, Chiaro G, Ciprini S, Claus R, Cohen-Tanugi J, Conrad J, Cutini S, Dalton M, D'Ammando F, de Angelis A, de Palma F, Dermer CD, Digel SW, Di Venere L, do Couto e Silva E, Drell PS, Drlica-Wagner A, Favuzzi C, Fegan SJ, Ferrara EC, Focke WB, Franckowiak A, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Germani S, Giglietto N, Giordano F, Giroletti M, Glanzman T, Godfrey G, Gomez-Vargas GA, Grenier IA, Grove JE, Guiriec S, Gustafsson M, Hadasch D, Hanabata Y, Harding AK, Hayashida M, Hayashi K, Hewitt JW, Horan D, Hou X, Hughes RE, Inoue Y, Jackson MS, Jogler T, Jóhannesson G, Johnson AS, Kamae T, Kawano T, Knödlseder J, Kuss M, Lande J, Larsson S, Latronico L, Longo F, Loparco F, Lovellette MN, Lubrano P, Mayer M, Mazziotta MN, McEnery JE, Mehault J, Michelson PF, Mitthumsiri W, Mizuno T, Moiseev AA, Monte C, Monzani ME, Morselli A, Moskalenko IV, Murgia S, Nemmen R, Nu… See abstract for full author list ➔ Ackermann M, et al. Among authors: strong aw. Phys Rev Lett. 2014 Apr 18;112(15):151103. doi: 10.1103/PhysRevLett.112.151103. Epub 2014 Apr 17. Phys Rev Lett. 2014. PMID: 24785023
Search for Cosmic-Ray Electron and Positron Anisotropies with Seven Years of Fermi Large Area Telescope Data.
Abdollahi S, Ackermann M, Ajello M, Albert A, Atwood WB, Baldini L, Barbiellini G, Bellazzini R, Bissaldi E, Bloom ED, Bonino R, Bottacini E, Brandt TJ, Bruel P, Buson S, Caragiulo M, Cavazzuti E, Chekhtman A, Ciprini S, Costanza F, Cuoco A, Cutini S, D'Ammando F, de Palma F, Desiante R, Digel SW, Di Lalla N, Di Mauro M, Di Venere L, Donaggio B, Drell PS, Favuzzi C, Focke WB, Fukazawa Y, Funk S, Fusco P, Gargano F, Gasparrini D, Giglietto N, Giordano F, Giroletti M, Green D, Guiriec S, Harding AK, Jogler T, Jóhannesson G, Kamae T, Kuss M, Larsson S, Latronico L, Li J, Longo F, Loparco F, Lubrano P, Magill JD, Malyshev D, Manfreda A, Mazziotta MN, Meehan M, Michelson PF, Mitthumsiri W, Mizuno T, Moiseev AA, Monzani ME, Morselli A, Negro M, Nuss E, Ohsugi T, Omodei N, Paneque D, Perkins JS, Pesce-Rollins M, Piron F, Pivato G, Principe G, Rainò S, Rando R, Razzano M, Reimer A, Reimer O, Sgrò C, Simone D, Siskind EJ, Spada F, Spandre G, Spinelli P, Strong AW, Tajima H, Thayer JB, Torres DF, Troja E, Vandenbroucke J, Zaharijas G, Zimmer S; Fermi-LAT Collaboration. Abdollahi S, et al. Among authors: strong aw. Phys Rev Lett. 2017 Mar 3;118(9):091103. doi: 10.1103/PhysRevLett.118.091103. Epub 2017 Mar 1. Phys Rev Lett. 2017. PMID: 28306280 Free article.
Measurement of the cosmic ray e+ +e- spectrum from 20 GeV to 1 TeV with the Fermi Large Area Telescope.
Abdo AA, Ackermann M, Ajello M, Atwood WB, Axelsson M, Baldini L, Ballet J, Barbiellini G, Bastieri D, Battelino M, Baughman BM, Bechtol K, Bellazzini R, Berenji B, Blandford RD, Bloom ED, Bogaert G, Bonamente E, Borgland AW, Bregeon J, Brez A, Brigida M, Bruel P, Burnett TH, Caliandro GA, Cameron RA, Caraveo PA, Carlson P, Casandjian JM, Cecchi C, Charles E, Chekhtman A, Cheung CC, Chiang J, Ciprini S, Claus R, Cohen-Tanugi J, Cominsky LR, Conrad J, Cutini S, Dermer CD, de Angelis A, de Palma F, Digel SW, Di Bernardo G, do Couto E Silva E, Drell PS, Dubois R, Dumora D, Edmonds Y, Farnier C, Favuzzi C, Focke WB, Frailis M, Fukazawa Y, Funk S, Fusco P, Gaggero D, Gargano F, Gasparrini D, Gehrels N, Germani S, Giebels B, Giglietto N, Giordano F, Glanzman T, Godfrey G, Grasso D, Grenier IA, Grondin MH, Grove JE, Guillemot L, Guiriec S, Hanabata Y, Harding AK, Hartman RC, Hayashida M, Hays E, Hughes RE, Jóhannesson G, Johnson AS, Johnson RP, Johnson WN, Kamae T, Katagiri H, Kataoka J, Kawai N, Kerr M, Knödlseder J, Kocevski D, Kuehn F, Kuss M, Lande J, Latronico L, Lemoine-Goumard M, Longo F, Loparco F, Lott B, Lovellette MN, Lubrano P, Madejski GM, Makeev A, Massai MM, Mazziotta MN, … See abstract for full author list ➔ Abdo AA, et al. Among authors: strong aw. Phys Rev Lett. 2009 May 8;102(18):181101. doi: 10.1103/PhysRevLett.102.181101. Epub 2009 May 4. Phys Rev Lett. 2009. PMID: 19518855
510 results